IndraLab

Statements


MiR-320b activates USP37. 5 / 5
| 5

reach
"MiR-320b inhibits IH mediated lung cancer progression by targeting USP37."

reach
"These findings have confirmed that miR-320b inhibits IH mediated lung cancer progression by targeting USP37."

reach
"Taken together, our data suggested that miR-320b inhibited IH mediated lung cancer progression by targeting USP37."

reach
"The results revealed that 6IH treatment could decrease the expression of miR-320b yet increase that of USP37 and CDT1, and the overexpression of miR-320b could downregulate the expressions of USP37 and CDT1, while the effect of miR-320b mimic on the expressions of miR-320b, USP37, and CDT1 could be counteracted by overexpressed CDT1 (oe-CDT1)."

reach
"Taken together, our study suggested that miR-320b suppressed CDT1 by targeting USP37 to inhibit the progression of lung cancer."